CarMax's Profit Squeeze and New CEO's Cost Cuts Fail to Alleviate Deep Structural Risks

What happened

CarMax shares slumped this week as lower used vehicle prices, while driving slight unit sales growth, significantly reduced gross profit, exposing ongoing margin compression in a cyclical market. This aligns with the DeepValue report's STRONG SELL stance, which highlights extreme leverage with net debt/EBITDA at 17.9x and interest coverage of only 0.3x, posing severe financial fragility. The new CEO has announced $200 million in expense reductions for fiscal 2027, aiming to structure the company for a challenging trading environment. However, these cost-cutting measures are insufficient to address the core issues of volatile free cash flow and rising credit costs in CarMax Auto Finance, as noted in the report. Overall, the news reinforces the bearish thesis that CarMax remains overvalued, with intrinsic value estimated at $13.71 per share versus a current price around $41, leaving little margin of safety.

Implication

The immediate profit squeeze from lower vehicle prices underscores CarMax's cyclical vulnerability, which could exacerbate in an economic downturn, threatening earnings further. Expense reductions for 2027 are a minor positive but do not directly tackle the urgent need for deleveraging, given the dangerously high net debt/EBITDA ratio of 17.9x and minimal interest coverage. With credit deterioration in CarMax Auto Finance continuing to rise, as highlighted by increased loss provisions, the company faces added operational risks that could impair financing and profitability. Governance uncertainty from recent CEO turnover compounds execution risk, making it difficult to trust near-term strategic initiatives without concrete evidence of balance sheet repair. Until sustained improvements in leverage, credit metrics, and free cash flow stability are demonstrated, the stock lacks downside protection and aligns with the DeepValue report's STRONG SELL recommendation.

Thesis delta

The new article confirms the margin pressure and strategic adjustments anticipated in the DeepValue report, reinforcing the existing STRONG SELL thesis based on high leverage and credit risks. While the CEO's cost-cutting plan introduces a potential efficiency gain, it does not materially shift the thesis, as it fails to address the fundamental financial fragility and cyclical exposures. Investors should await visible progress on deleveraging, such as reduced net debt/EBITDA and improved interest coverage, before considering any upgrade from the current bearish stance.